Magnesium Deficiency Causes a Reversible, Metabolic, Diastolic Cardiomyopathy.
Man Liu,Hong Liu,Feng Feng,An Xie,Gyeoung‐Jin Kang,Yang Zhao,Cody R. Hou,Xiaoxu Zhou,Samuel C. Dudley
DOI: https://doi.org/10.1161/JAHA.120.020205
IF: 6.106
2021-06-09
Journal of the American Heart Association
Abstract:Background Dietary Mg intake is associated with a decreased risk of developing heart failure, whereas low circulating Mg level is associated with increased cardiovascular mortality. We investigated whether Mg deficiency alone could cause cardiomyopathy. Methods and Results C57BL/6J mice were fed with a low Mg (low‐Mg, 15–30 mg/kg Mg) or a normal Mg (nl‐Mg, 600 mg/kg Mg) diet for 6 weeks. To test reversibility, half of the low‐Mg mice were fed then with nl‐Mg diet for another 6 weeks. Low‐Mg diet significantly decreased mouse serum Mg (0.38±0.03 versus 1.14±0.03 mmol/L for nl‐Mg; P <0.0001) with a reciprocal increase in serum Ca, K, and Na. Low‐Mg mice exhibited impaired cardiac relaxation (ratio between mitral peak early filling velocity E and longitudinal tissue velocity of the mitral anterior annulus e, 21.1±1.1 versus 15.4±0.4 for nl‐Mg; P =0.011). Cellular ATP was decreased significantly in low‐Mg hearts. The changes were accompanied by mitochondrial dysfunction with mitochondrial reactive oxygen species overproduction and membrane depolarization. cMyBPC (cardiac myosin‐binding protein C) was S ‐glutathionylated in low‐Mg mouse hearts. All these changes were normalized with Mg repletion. In vivo (2‐(2,2,6,6‐tetramethylpiperidin‐1‐oxyl‐4‐ylamino)‐2‐oxoethyl)triphenylphosphonium chloride treatment during low‐Mg diet improved cardiac relaxation, increased ATP levels, and reduced S ‐glutathionylated cMyBPC. Conclusions Mg deficiency caused a reversible diastolic cardiomyopathy associated with mitochondrial dysfunction and oxidative modification of cMyBPC. In deficiency states, Mg supplementation may represent a novel treatment for diastolic heart failure. Nonstandard Abbreviations and Acronyms cMyBPC cardiac myosin‐binding protein C E/e' ratio between mitral peak early filling velocity E and longitudinal tissue velocity of the mitral anterior annulus e low‐Mg mice fed with low‐Mg diet low→nl‐Mg mice fed with low‐Mg diet for 6 weeks and then normal Mg diet for another 6 weeks mitoTEMPO (2‐(2,2,6,6‐tetramethylpiperidin‐1‐oxyl‐4‐ylamino)‐2‐oxoethyl)triphenylphosphonium chloride nl‐Mg control mice fed with normal Mg diet ROS reactive oxygen species Clinical Perspective What Is New? Hypomagnesemia is common in diabetes mellitus, and is associated with worsening heart failure symptoms; Mg supplementation can improve these symptoms. Herein, we show that severe hypomagnesemia caused a reversible diastolic cardiomyopathy. The diastolic cardiomyopathy was associated with mitochondrial dysfunction and responded to mitochondrial antioxidant therapy. What Are the Clinical Implications? The causative relationship between hypomagnesemia and diastolic dysfunction may help explain previous epidemiological data linking heart failure and Mg. Mg repletion may help treat diastolic heart failure by improving mitochondrial function and reducing oxidative stress. In the United States, about 6.5 million people have heart failure, and the number is increasing yearly. 1 Half of the heart failure is heart failure with preserved ejection fraction (EF), and diastolic dysfunction is thought to be essential to the pathology. Cardiac diastolic dysfunction is characterized by the reduced ability of the left ventricle to relax and fill with blood adequately. Because of poor understanding of the underlying pathophysiology, there are no specific treatments currently for diastolic dysfunction. 2 , 3 , 4 Previously, our group has studied hypertensive and diabetic mouse models of isolated diastolic dysfunction and heart failure with preserved EF and confirmed that cardiac mitochondrial oxidative stress is central to dia -Abstract Truncated-
cardiac & cardiovascular systems